[
  {
    "case_id": "SL_001",
    "disease": "ovarian_cancer",
    "subtype": "high_grade_serous",
    "stage": "IVB",
    "mutations": [
      {
        "gene": "BRCA1",
        "hgvs_p": "p.C61G",
        "chrom": "17",
        "pos": 43070943,
        "ref": "A",
        "alt": "T",
        "consequence": "missense"
      }
    ],
    "ground_truth": {
      "synthetic_lethality_detected": true,
      "known_sl_pairs": [
        "BRCA1+PARP"
      ],
      "effective_drugs": [
        "Olaparib",
        "Niraparib",
        "Rucaparib"
      ],
      "broken_pathways": [
        "HR"
      ],
      "essential_pathways": [
        "PARP"
      ],
      "depmap_essentiality": {
        "BRCA1": 0.92
      },
      "clinical_evidence": {
        "olaparib_fda_approved": true,
        "olaparib_indication": "BRCA-mutated ovarian cancer",
        "response_rate": 0.65
      }
    }
  },
  {
    "case_id": "SL_002",
    "disease": "ovarian_cancer",
    "subtype": "high_grade_serous",
    "stage": "IIIB",
    "mutations": [
      {
        "gene": "BRCA2",
        "hgvs_p": "p.K3326*",
        "chrom": "13",
        "pos": 32936750,
        "ref": "A",
        "alt": "T",
        "consequence": "stop_gained"
      }
    ],
    "ground_truth": {
      "synthetic_lethality_detected": true,
      "known_sl_pairs": [
        "BRCA2+PARP"
      ],
      "effective_drugs": [
        "Olaparib",
        "Niraparib"
      ],
      "broken_pathways": [
        "HR"
      ],
      "essential_pathways": [
        "PARP"
      ],
      "depmap_essentiality": {
        "BRCA2": 0.88
      },
      "clinical_evidence": {
        "olaparib_fda_approved": true,
        "response_rate": 0.6
      }
    }
  },
  {
    "case_id": "SL_003",
    "disease": "ovarian_cancer",
    "subtype": "high_grade_serous",
    "stage": "IVB",
    "mutations": [
      {
        "gene": "MBD4",
        "hgvs_p": "p.R346fs",
        "chrom": "3",
        "pos": 129430488,
        "ref": "A",
        "alt": "AT",
        "consequence": "frameshift_variant"
      },
      {
        "gene": "TP53",
        "hgvs_p": "p.R175H",
        "chrom": "17",
        "pos": 7577120,
        "ref": "G",
        "alt": "A",
        "consequence": "missense"
      }
    ],
    "ground_truth": {
      "synthetic_lethality_detected": true,
      "known_sl_pairs": [
        "MBD4+PARP",
        "TP53+ATR"
      ],
      "effective_drugs": [
        "Olaparib",
        "Ceralasertib"
      ],
      "broken_pathways": [
        "BER",
        "G1/S Checkpoint"
      ],
      "essential_pathways": [
        "HR",
        "ATR/CHK1"
      ],
      "depmap_essentiality": {
        "MBD4": 0.8,
        "TP53": 0.75
      },
      "clinical_evidence": {
        "olaparib_fda_approved": true,
        "ceralasertib_status": "clinical_trials"
      }
    }
  },
  {
    "case_id": "SL_004",
    "disease": "ovarian_cancer",
    "subtype": "high_grade_serous",
    "stage": "IIIC",
    "mutations": [
      {
        "gene": "TP53",
        "hgvs_p": "p.R273H",
        "chrom": "17",
        "pos": 7577539,
        "ref": "G",
        "alt": "A",
        "consequence": "missense"
      }
    ],
    "ground_truth": {
      "synthetic_lethality_detected": true,
      "known_sl_pairs": [
        "TP53+ATR"
      ],
      "effective_drugs": [
        "Ceralasertib",
        "Adavosertib"
      ],
      "broken_pathways": [
        "G1/S Checkpoint"
      ],
      "essential_pathways": [
        "ATR/CHK1"
      ],
      "depmap_essentiality": {
        "TP53": 0.7
      },
      "clinical_evidence": {
        "ceralasertib_status": "clinical_trials"
      }
    }
  },
  {
    "case_id": "SL_005",
    "disease": "ovarian_cancer",
    "subtype": "high_grade_serous",
    "stage": "IVB",
    "mutations": [
      {
        "gene": "BRCA1",
        "hgvs_p": "p.Q563*",
        "chrom": "17",
        "pos": 43094450,
        "ref": "C",
        "alt": "T",
        "consequence": "stop_gained"
      },
      {
        "gene": "TP53",
        "hgvs_p": "p.R175H",
        "chrom": "17",
        "pos": 7577120,
        "ref": "G",
        "alt": "A",
        "consequence": "missense"
      }
    ],
    "ground_truth": {
      "synthetic_lethality_detected": true,
      "known_sl_pairs": [
        "BRCA1+PARP",
        "TP53+ATR"
      ],
      "effective_drugs": [
        "Olaparib",
        "Ceralasertib"
      ],
      "broken_pathways": [
        "HR",
        "G1/S Checkpoint"
      ],
      "essential_pathways": [
        "PARP",
        "ATR/CHK1"
      ],
      "depmap_essentiality": {
        "BRCA1": 0.95,
        "TP53": 0.75
      },
      "clinical_evidence": {
        "olaparib_fda_approved": true,
        "response_rate": 0.7
      }
    }
  },
  {
    "case_id": "SL_006",
    "disease": "ovarian_cancer",
    "subtype": "high_grade_serous",
    "stage": "IIIC",
    "mutations": [
      {
        "gene": "OR4F5",
        "hgvs_p": "p.V123M",
        "chrom": "1",
        "pos": 920000,
        "ref": "G",
        "alt": "A",
        "consequence": "missense"
      }
    ],
    "ground_truth": {
      "synthetic_lethality_detected": false,
      "known_sl_pairs": [],
      "effective_drugs": [],
      "broken_pathways": [],
      "essential_pathways": [],
      "depmap_essentiality": {
        "OR4F5": 0.1
      },
      "clinical_evidence": {
        "note": "Benign variant, no known SL"
      }
    }
  },
  {
    "case_id": "SL_007",
    "disease": "ovarian_cancer",
    "subtype": "endometrioid",
    "stage": "II",
    "mutations": [
      {
        "gene": "HLA-A",
        "hgvs_p": "p.A74T",
        "chrom": "6",
        "pos": 29910284,
        "ref": "G",
        "alt": "A",
        "consequence": "missense"
      }
    ],
    "ground_truth": {
      "synthetic_lethality_detected": false,
      "known_sl_pairs": [],
      "effective_drugs": [],
      "broken_pathways": [],
      "essential_pathways": [],
      "depmap_essentiality": {
        "HLA-A": 0.15
      },
      "clinical_evidence": {
        "note": "Non-essential gene, no SL expected"
      }
    }
  },
  {
    "case_id": "SL_008",
    "disease": "ovarian_cancer",
    "subtype": "mucinous",
    "stage": "IIIB",
    "mutations": [
      {
        "gene": "KRAS",
        "hgvs_p": "p.G12D",
        "chrom": "12",
        "pos": 25398284,
        "ref": "G",
        "alt": "A",
        "consequence": "missense"
      }
    ],
    "ground_truth": {
      "synthetic_lethality_detected": false,
      "known_sl_pairs": [],
      "effective_drugs": [
        "Trametinib"
      ],
      "broken_pathways": [
        "MAPK"
      ],
      "essential_pathways": [],
      "depmap_essentiality": {
        "KRAS": 0.25
      },
      "clinical_evidence": {
        "note": "KRAS mutation, but no SL relationship"
      }
    }
  },
  {
    "case_id": "SL_009",
    "disease": "breast_cancer",
    "subtype": "triple_negative",
    "stage": "IIB",
    "mutations": [
      {
        "gene": "BRCA1",
        "hgvs_p": "p.E23*",
        "chrom": "17",
        "pos": 43045694,
        "ref": "G",
        "alt": "T",
        "consequence": "stop_gained"
      },
      {
        "gene": "PIK3CA",
        "hgvs_p": "p.E545K",
        "chrom": "3",
        "pos": 178952085,
        "ref": "G",
        "alt": "A",
        "consequence": "missense"
      }
    ],
    "ground_truth": {
      "synthetic_lethality_detected": true,
      "known_sl_pairs": [
        "BRCA1+PARP"
      ],
      "effective_drugs": [
        "Olaparib",
        "Niraparib"
      ],
      "broken_pathways": [
        "HR"
      ],
      "essential_pathways": [
        "PARP"
      ],
      "depmap_essentiality": {
        "BRCA1": 0.9,
        "PIK3CA": 0.3
      },
      "clinical_evidence": {
        "olaparib_fda_approved": true,
        "note": "BRCA1 SL dominates, PIK3CA secondary"
      }
    }
  },
  {
    "case_id": "SL_010",
    "disease": "ovarian_cancer",
    "subtype": "high_grade_serous",
    "stage": "IVB",
    "mutations": [
      {
        "gene": "BRCA2",
        "hgvs_p": "p.N372H",
        "chrom": "13",
        "pos": 32911507,
        "ref": "A",
        "alt": "C",
        "consequence": "missense",
        "germline": true
      },
      {
        "gene": "TP53",
        "hgvs_p": "p.R248W",
        "chrom": "17",
        "pos": 7577539,
        "ref": "C",
        "alt": "T",
        "consequence": "missense",
        "germline": false
      }
    ],
    "ground_truth": {
      "synthetic_lethality_detected": true,
      "known_sl_pairs": [
        "BRCA2+PARP",
        "TP53+ATR"
      ],
      "effective_drugs": [
        "Olaparib",
        "Ceralasertib"
      ],
      "broken_pathways": [
        "HR",
        "G1/S Checkpoint"
      ],
      "essential_pathways": [
        "PARP",
        "ATR/CHK1"
      ],
      "depmap_essentiality": {
        "BRCA2": 0.85,
        "TP53": 0.72
      },
      "clinical_evidence": {
        "olaparib_fda_approved": true,
        "note": "Germline BRCA2 + somatic TP53"
      }
    }
  }
]